Elekta’s latest Monaco release features up to four times faster calculation speed for reduced radiotherapy planning times

Monaco 5.11 makes debut at ESTRO 35 in Italy
TURIN, Italy, April 29 – Elekta is pleased to announce that Monaco® version
5.11, the latest update to its industry-leading treatment planning software, is
available for clinical release. Real-world testing has shown that Monaco version
5.11 provides significant performance speed enhancements over prior versions.
Users can now attain calculation speeds up to four times faster than in previous
versions of Monaco. With the industry’s gold standard Monte Carlo algorithm,
users can achieve robust accuracy combined with speed and performance.

Fast plan calculation time is just one of the many characteristics in Monaco
designed to improve overall efficiency. Monaco templates enable users to easily
import and export treatment plans, facilitating sharing across departments and
organizations. With the ability to create multiple prescription plans at one
time, overall planning time is reduced. Additionally, improved data sharing
creates additional opportunities to optimize individual treatment plans to meet
the needs of each patient.

“The optimization speed enhancements in version 5.11, combined with previous
innovations, such as template planning, provide substantial improvements in
planning workflow efficiencies, while continuing to deliver highly accurate
treatment plans using Monte Carlo dose calculations,” says Dr. Sotiri Stathakis,
Associate Professor, Radiation Oncology and Radiology at University of Texas
Health Science Center in San Antonio, Texas. “We have been testing Monaco
version 5.11 for several months and, so far, we have seen up to 3-4 times
reduction in the optimization of VMAT plans equivalent to a 70 percent reduction
in optimization times.”

“Elekta has a long history of providing software solutions that help to optimize
patient care regardless of the technology platform used in treatment,” says
Richard Stark, Senior Vice President, Comprehensive Oncology Solutions. “Monaco
delivers high performance and high precision radiotherapy treatment planning for
virtually all major treatment techniques. When used in conjunction with Versa
HD™, clinicians can now deliver dynamic radiosurgery by modulating multiple
parameters at the time of treatment to achieve highly-precise dose deposition.
Moreover, the availability of treatment templates can help to reduce the
complexity of care, an especially significant advantage to both busy radiation
oncology departments as well as health care facilities that have more
constrained personnel and technology resources.”

Monaco is one of several innovations to be highlighted at the Elekta exhibit
(booths #200 and #500) during the 2016 meeting of the European Society for
Therapeutic Radiation & Oncology (ESTRO 35), April 29-May 3 in Turin, Italy.

For more information on Monaco 5.11, visit www.elekta.com/monaco.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on April 29, 2016.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.